SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001005286-24-000056
Filing Date
2024-05-07
Accepted
2024-05-07 16:48:10
Documents
13
Period of Report
2024-05-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K lndc-20240501.htm   iXBRL 8-K 28193
  Complete submission text file 0001005286-24-000056.txt   152308

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lndc-20240501.xsd EX-101.SCH 1983
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lndc-20240501_lab.xml EX-101.LAB 21885
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lndc-20240501_pre.xml EX-101.PRE 12591
16 EXTRACTED XBRL INSTANCE DOCUMENT lndc-20240501_htm.xml XML 2690
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

IRS No.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0528
Type: 8-K | Act: 34 | File No.: 000-27446 | Film No.: 24922830
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)